|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Alfacell Corp., of Bloomfield, N.J., expanded its research collaboration with the National Cancer Institute of the NIH under which the NCI will evaluate Alfacell's Onconase as a radiation enhancer. Previous research showed Onconase causes an increase in both tumor blood flow and median tumor oxygen partial pressure. Alfacell develops ribonucleases for cancer and other diseases.
Alliance Pharmaceutical Corp., of San Diego, said it, Baxter Healthcare Corp., of Deerfield, Ill., and their joint venture, PFC Therapeutics LLC, have agreed to explore avenues to realize the value of PFC and to negotiate in good faith. PFC was created to oversee development and sales of ...